Why has the Mesoblast share price crashed 40% since April?

The tech share extends losses today.

| More on:
Red arrow going down and symbolising a falling share price.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Mesoblast shares continue their downward slide today 
  • The company has seen heavy selling pressure in 2022 alongside an unwind of the tech trade 
  • The Mesoblast share price has tumbled more than 69% into the red over the last 12 months 

The Mesoblast Limited (ASX: MSB) share price has started the day well and is now trading around 4% higher at 68.5 cents apiece.

Despite the gain today, Mesoblast shares have struggled since April. They are down around 40% since that time, in continuation of a longer-term downtrend.

Mesoblast is also down 51% this year to date, amid a heavy sell-off in ASX tech shares. In the last 2 weeks, a plunge in the broader market has pulled the share lower.

What's up with the Mesoblast share price?

Investors have been selling the Mesoblast share price down on no news. The company did release its financial and operational highlights for the last quarter on 1 June, however, the market was unfazed.

In fact, shares have been trending south for over 1 year now, having fallen hard from a sharp peak of $4.60 in December 2020.

Since then, shares have rolled lower and now trade at both 2-year and 52-week lows.

With the trend in place, there's been no support from the market, not in 2022 anyway. The S&P/ASX All Technology Index (ASX: XJO) is also at yearly lows having sunk 38% this year to date.

Furthermore, Mesoblast has seen proceedings started against it in a Federal Court of Australia back in May.

According to TMF at the time, the claimant – someone who bought shares between 2018-2020 – alleges Mesoblast "engaged in unlawful conduct that misled the market about remestemcel-L".

"Mesoblast has reportedly faced multiple class actions in the US on similar allegations," TMF added.

Nevertheless, the Mesoblast share price has tumbled more than 69% into the red over the last 12 months, as seen below.

TradingView Chart

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Technology Shares

A man in full American NFL playing kit crouches over with his arms across his chest in a defensive stance against a dark background.
Technology Shares

ASX 300 tech stock charges 7% higher to record high on stellar results

This tech stock delivered another impressive result this morning.

Read more »

a man sits at his desk wearing a business shirt and tie and has a hearty laugh at something on his mobile phone.
Technology Shares

Up 87% in 12 months: Why this ASX tech share is still a top buy

This technology business still has loads of potential, according to a fund manager.

Read more »

a group of three cybersecurity experts stand with satisfied looks on their faces with one holding a laptop computer while he group stands in front of a large bank of computers and electronic equipment.
Technology Shares

2 ASX 200 tech stocks Morgans rates as buys

The leading broker has named a couple of shares to buy right now.

Read more »

Man smiling at a laptop because of a rising share price.
Technology Shares

Is it time to buy ASX data centre shares?

ASX data centre shares have been rebounding lately. Will they continue to?

Read more »

a group of people sit around a computer in an office environment.
Earnings Results

Guess which ASX 200 tech stock is rocketing 12% on record results

Another half, another record result from this high-quality company.

Read more »

Man on his laptop standing next to data centres.
AI Stocks

3 reasons to buy this $9 billion ASX 200 AI stock today

A leading expert forecasts this $9 billion ASX 200 AI stock will deliver “meaningful earnings upside”.

Read more »

Business people discussing project on digital tablet.
Technology Shares

After its result, what does Macquarie think Xero shares are worth?

Here's what the leading broker is saying about this tech stock.

Read more »

A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.
Technology Shares

Gentrack share price down 5% on half-year results

Let's unpack what was reported.

Read more »